BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20250820T235027EDT-2469UZNhwg@132.216.98.100
DTSTAMP:20250821T035027Z
DESCRIPTION:\n	JEWISH GENERAL HOSPITAL\n	DEPARTMENT OF MEDICINE\n	MONDAY VIRTU
 AL MEDICAL GRAND ROUNDS\n	12:30 - 1:30 PM\n	聽\n\n\n	聽\n\nMarch 7\n\nINNOVATIO
 N IN TYPE 1 DIABETES: A REFRESHER ON GLUCOSE MONITORING\, NEWS ON NEW INSU
 LINS AND A WORD ON INSULIN PUMPS\n	\n	Agnieszka Majdan\, MD\n	Assistant Profe
 ssor of Medicine\, 9I制作厂免费\n	Division of Endocrinology\, Jewish G
 eneral Hospital\n\nEducational Objectives:\n	1. To understand the basics of
  continuous glucose monitoring systems and how to interpret their data\n	2.
  To recognize the differences and similarities among currently used short 
 and long acting insulins\n\nContact Person: Mark Trifiro\, MD\, Chief\, Di
 vision of Endocrinology\, Tel. 514-340-8222 ext. 2397.\n\n**\n\nMarch 14\n
 \nCOVID-19 AND ITS IMPACT ON LUNG CANCER CARE - THE JGH EXPERIENCE\n	\n	Jaso
 n Agulnik\, MD\n	Associate Professor of Medicine\, 9I制作厂免费\n	Chief
 \, Division of Pulmonary Medicine\, Jewish General Hospital\n	&\n	Carmela Pe
 pe\, MD\n	Assistant Professor of Medicine\, 9I制作厂免费\n	Division of 
 Pulmonary Medicine\, Jewish General Hospital\n\nEducational Objectives:\n	1
 . Review COVID statistics affecting lung cancer care\n	2. Impact on the tra
 jectory of care in lung cancer\n\nContact Person: Carmela Pepe\, MD\, Divi
 sion of Pulmonary Medicine\, Tel. 514-340-7900.\n	聽\n\n**\n	\n	March 21\n\nMA
 RCH\, DVT AWARENESS MONTH\n	NEW ANTICOAGULANTS: MOVING BEYOND THE DIRECT OR
 AL ANTICOAGULANTS \n	\n	Jeffrey Weitz\, MD\, FRCPC\, FRSC\, FACP\n	President\
 , International Society of Thrombosis and Haemostasis\n	Professor of Medici
 ne & Biochemistry\, McMaster University\n	Heart & Stroke Foundation/J.F. Mu
 stard Chair in Cardiovascular Research\n	Canada Research Chair (Tier 1) in 
 Thrombosis\n	Executive Director\, Thrombosis & Atherosclerosis Research Ins
 titute\n\nEducational Objectives:\n	1. To review the role of factor XI in t
 hrombosis and hemostasis\n	2. To present the clinical data with factor XI i
 nhibitors\n	3. To provide perspective on the potential for factor XI inhibi
 tors in the era of direct oral anticoagulants\n\nContact Person: Susan Kah
 n\, MD\, Division of Internal Medicine\, Tel. 514-340-8222 extension 24667
 \n\n**\n	\n	March 28\n\nIDENTIFYING DIFFERENCES IN THE PROFILE OF SOCIALLY I
 SOLATED OLDER PERSONS DURING THE PANDEMIC USING THE ESOGER1 TOOL (FIRST LE
 VEL SOCIO-GERIATRIC EVALUATION)\n	\n	Cyrille Launay\, MD \n	Assistant Profess
 or of Medicine\, 9I制作厂免费\n	Division of Geriatric Medicine\, Jewis
 h General Hospital\n	&\n	Nadia Sourial\, PhD\n	Assistant professor\, Departme
 nt of Health Management\, Evaluation and Policy\, School of Public Health\
 , University of Montreal\n	Research Center of the University of Montreal Ho
 spital Center\n\nEducational Objectives:\n	1. To understand how the pandemi
 c may have led to different pathways to social isolation\n	2. To highlight 
 the importance of targeting interventions to different profiles of sociall
 y isolated older adults\n	3. To highlight the impact of a telehealth interv
 ention on the trajectories of frailty\n\nContact Person: Jos茅 Morais\, MD\
 , Chief\, Division of Geriatric Medicine\, Tel. 514-340-7501.\n\n\n	Click h
 ere for more info and the Microsoft Teams link\, and to watch previous Rou
 nds.\n\n聽\n
DTSTART;VALUE=DATE:20220307
DTEND;VALUE=DATE:20220328
SUMMARY:JGH Virtual Medical Grand Rounds - March 2022
URL:/medhealthsci/channels/event/jgh-virtual-medical-g
 rand-rounds-march-2022-338128
END:VEVENT
END:VCALENDAR